Comparative clinical trial of Bharangi moola and Kantakari panchang in Tamaka shwasa.

Pharmacognostical study of Bharangi moola (Clerodendrum serratum (Linn.) Moon.) samples collected from various markets and comparative clinical trial of Bharangi moola (Clerodendrum serratum (Linn.) with its Pratinidhi Kantakari panchanga (Solanum xanthocarpum Schrad. & Wendl) in Tamaka shwasa. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/057136

Enrollment

Registered

2023-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical signs and symptoms of Tamaka Shwasa-1)Pratiloma Vayu (prolonged expiration) 2)Ghurghuraka (wheeze) 3)Shwasakastata (Dyspnoea) 4)Kapha Nistivanam (Spitting of sputum) 5)Kasa (coughing) 6)Asino Labhate Saukhyam (comfortable in orthopnea(seating) position) 7)Peenasa (nasal congestion) 8)Shayanah Shwasapiditah (patient had more Dyspnoea when lying down) 9)Shwasa Vega (Frequency) 10) Krcchrat bhasitam (Difficulty in Speaking)

Exclusion criteria

Exclusion criteria: Age less than 18 and more than 60 years Severe renal/Hepatic disease HIV positive cases Pregnant/lactating mother/HTN Patient taking inhaler pump.

Design outcomes

Primary

Measure	Time frame
Shwasakastata(Dyspnoea)Timepoint: 4 week	—

Secondary

Measure	Time frame
Improvement in quality of lifeTimepoint: 4 week	—

Countries

India

Contacts

Public ContactDr Anoop Indoria

Government Ayurved College, Vadodara

snghsmn@gmail.com9510172204

Outcome results